T. Rowe Price Associates
ASXC

T. Rowe Price Associates’s Asensus Surgical, Inc. ASXC Stock Holding History

T. Rowe Price Associates’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-185,500
Closed -$43K – 3061
2024
Q1 		$43K Hold
185,500
– – ﹤0.01% 2893
2023
Q4 		$60K Hold
185,500
– – ﹤0.01% 2782
2023
Q3 		$51K Hold
185,500
– – ﹤0.01% 2778
2023
Q2 		$94K Hold
185,500
– – ﹤0.01% 2710
2023
Q1 		$123K Sell
185,500
-40,300
-18% -$27.3K ﹤0.01% 2646
2022
Q4 		$78K Sell
225,800
-70,300
-24% -$28.6K ﹤0.01% 2758
2022
Q3 		$134K Buy
296,100
+86,400
+41% +$45K ﹤0.01% 2660
2022
Q2 		$83K Sell
209,700
-21,241
-9% -$9.48K ﹤0.01% 2796
2022
Q1 		$145K Buy
230,941
+33,100
+17% +$25.5K ﹤0.01% 2779
2021
Q4 		$220K Buy
197,841
+71,000
+56% +$110K ﹤0.01% 2722
2021
Q3 		$235K Buy
126,841
+24,600
+24% +$55.2K ﹤0.01% 2664
2021
Q2 		$324K Sell
102,241
-759
-0.7% -$1.9K ﹤0.01% 2569
2021
Q1 		$335K Buy
+103,000
New +$373K ﹤0.01% 2527
2019
Q4 		– Sell
-11,476
Closed -$92K – 2558
2019
Q3 		$92K Buy
11,476
+69
+0.6% +$938 ﹤0.01% 2458
2019
Q2 		$202K Buy
11,407
+72
+0.6% +$1.58K ﹤0.01% 2411
2019
Q1 		$351K Buy
11,335
+2,769
+32% +$92.8K ﹤0.01% 2243
2018
Q4 		$252K Sell
8,566
-22,173
-72% -$1.01M ﹤0.01% 2348
2018
Q3 		$2.32M Buy
30,739
+22,358
+267% +$1.51M ﹤0.01% 1583
2018
Q2 		$475K Buy
8,381
+2,673
+47% +$97.4K ﹤0.01% 2162
2018
Q1 		$126K Buy
5,708
+46
+0.8% +$1.05K ﹤0.01% 2478
2017
Q4 		$142K Buy
+5,662
New +$174K ﹤0.01% 2473

Other funds holding ASXC

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

T. Rowe Price Associates's ASXC Position: Q2 2024 in Review

T. Rowe Price Associates sold out of Asensus Surgical, Inc. (ASXC) in Q2 2024, closing a stake of 185,500 shares — an estimated $43K sold.

T. Rowe Price Associates first reported a position in ASXC in Q4 2017 and held it in 21 quarters. The position peaked at $2.32M in Q3 2018. 64 funds tracked by Wall St. Rank hold ASXC as of Q2 2024.

  • T. Rowe Price Associates reported no remaining Asensus Surgical, Inc. position as of Q2 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 185,500 Asensus Surgical, Inc. shares in Q2 2024, an estimated $43K.
  • T. Rowe Price Associates first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 21 quarters.
  • T. Rowe Price Associates's Asensus Surgical, Inc. position peaked at $2.32M in Q3 2018.
  • 64 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2024.

Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.